Results 141 to 150 of about 284,051 (203)

Prevalent Coronary Artery Disease and Undertreatment in Heterozygous Familial Hypercholesterolemia -Real-World Data and "Heterozygous FH Score" from FAME Study. [PDF]

J Atheroscler Thromb, 2022
Nohara A.
europepmc   +1 more source

Impact of a whole food, plant-based diet on LDL-cholesterol and cardiovascular risk factors in adults with heterozygous familial hypercholesterolemia: a randomized, two-period, two-treatment, crossover, fully controlled feeding trial. [PDF]

Nat Commun
Lessard-Lord J, Guay V, Rancourt-Bouchard M, Couture P, Gangloff A, Blais J, Tremblay AJ, Greffard K, Bilodeau JF, Rudkowska I, Drouin-Chartier JP.   +10 more
europepmc   +1 more source

Efficacy and outcomes of inclisiran in the management of homozygous and heterozygous familial hypercholesterolemia: a systematic review and meta-analysis. [PDF]

Ann Med Surg (Lond)
Khan Z, Singh A, Haseeb Ur Rasool M, Qasim N, Yafaa Naveed Chaudhary M, Syed S, Riaz M, Rehman W, Rehman I, Islam R, Islam H, Muhammad A, Devi R, Wei CR, Naaz F, Akilimali A.   +15 more
europepmc   +1 more source

Echocardiographic Calcium Score of Aortic Valve Correlates with Coronary Artery Calcium Score in Heterozygous Familial Hypercholesterolemia. [PDF]

Life (Basel)
Cefalù AB, Nardi E, Giammanco A, Gagliardo CM, Barbagallo CM, La Grutta L, Toia P, Brucato F, Scrimali C, Fasciana TMG, Spina R, Lanza M, Vitale F, Noto D, Averna M.   +14 more
europepmc   +1 more source

<i>Proprotein Convertase Subtilisin</i>/<i>Kexin Type 9</i> (<i>PCSK9</i>) Inhibitor Therapy Reduces the Level of DNA Damage in Patients with Heterozygous Familial Hypercholesterolemia. [PDF]

Int J Mol Sci
Woźniak E, Woźniak A, Pawlos A, Broncel M, Satała J, Bukowska B, Gorzelak-Pabiś P.   +6 more
europepmc   +1 more source

Lipoprotein(a) is associated with DNA damage in patients with heterozygous familial hypercholesterolemia. [PDF]

Sci Rep
Woźniak E, Broncel M, Woźniak A, Satała J, Pawlos A, Bukowska B, Gorzelak-Pabiś P.   +6 more
europepmc   +1 more source

Efficacy and Safety of Oral PCSK9 Inhibitor Enlicitide in Adults With Heterozygous Familial Hypercholesterolemia: A Randomized Clinical Trial.

JAMA
Ballantyne CM, Gellis L, Tardif JC, Banka P, Navar AM, Asprusten EA, Scott R, Stroes ESG, Froman S, Mendizabal G, Wang F, Catapano AL.   +11 more
europepmc   +1 more source

Resilient Older Subjects with Heterozygous Familial Hypercholesterolemia, Baseline Differences and Associated Factors. [PDF]

Int J Mol Sci
Climent E, González-Guerrero A, Marco-Benedí V, García-Andreu MD, Mediavilla-García JD, Suárez-Tembra M, Benaiges D, Pintó X, Pedro-Botet J.   +8 more
europepmc   +1 more source

Adherence to the Healthy Nordic Food Index is associated with reduced plasma levels of inflammatory markers in patients with heterozygous familial hypercholesterolemia. [PDF]

Atheroscler Plus
Løvheim EB, Retterstøl K, Narverud I, Bogsrud MP, Halvorsen B, Ueland T, Aukrust P, Holven KB.   +7 more
europepmc   +1 more source

P5.22 CAROTID AND AORTIC STIFFNESS IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA

Artery Research, 2011
A.I. Ershova, A.N. Meshkov, T.A. Rozhkova, A.N. Rogoza, T.V. Balakhonova, S.A. Boytsov   +5 more
doaj   +1 more source